Opinion|Videos|December 4, 2024

Case 1: Metastatic Castration- Sensitive Prostate Cancer (mCSPC)

Key Takeaways

Panelists discuss how the management of metastatic castration-sensitive prostate cancer involves a multidisciplinary approach, utilizing androgen deprivation therapy, chemotherapy, and novel agents to control disease progression and improve patient survival.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Latest CME